Sfoglia per AUTORE
INNOCENTI I
Collezione AOU Alessandria

  

Items : 8

Real-world safety and effectiveness of zanubrutinib vs ibrutinib in CLL: the CLL-ZANU2024 Italian cohort. in Blood advances / Blood Adv. 2026 Mar 10;10(5):1687-1699. doi: 10.1182/bloodadvances.2025018757.
2026
AOU Alessandria

Gentile M; Gattei V; Morabito F; Tripepi G; Martino EA; Pitino A; Vigna E; Pasquale R; Ferrarini I; Moia R; Visentin A; Sanna A; Motta M; Moratti M; Sportoletti P; Chiarenza A; Maggi A; Zammit V; Merli M; Innocenti I; Giordano C; Nocilli L; Postorino M; Stelitano C; Ferrario A; Frustaci AM; Riva M; Pepe S; Ibatici A; et alii...

Clinical Outcomes in Double-Exposed Chronic Lymphocytic Leukemia Patients in Italy. in Hematological oncology / Hematol Oncol. 2026 Mar;44(2):e70184. doi: 10.1002/hon.70184.
2026
AOU Alessandria

Innocenti I; Sanna A; Angeletti I; Gentile M; Sportoletti P; Scortechini I; Farina L; Giordano A; Quaresmini G; Moia R; Catania G; Mattiello V; Morelli F; Fresa A; Vitale C; Giannarelli D; Visentin A; Autore F; Coscia M; Trentin L; Laurenti L;

No lymphocytosis increase after cBTKi is a rare phenomenon except for CD49d-positive CLL mainly expressed in trisomy 12. in Blood advances / Blood Adv. 2026 Jun 9;10(11):3983-3986. doi: 10.1182/bloodadvances.2025018640.
2026
AOU Alessandria

Krampera M; Farina G; Gentile M; Gaidano G; Gattei V; Abbate PL; Quaranta T; Stirparo L; Tomasso A; Autore F; Tissino E; Zucchetto A; Moia R; Martino EA; Giannarelli D; Catania G; Murru R; Moratti M; Pasquale R; Galitzia A; Ferrarini I; Favrin G; Montalbano MC; Vitale C; Mosca A; Guglielmi F; Laurenti L; Visentin A; Innao V; et alii...

2026
AOU Alessandria

Laurenti L; Renzo ND; Coscia M; Angotzi F; Figuera A; Principe MID; Marasca R; Martina VD; Derenzini E; Caracciolo D; Murru R; Conte E; Cantelli M; Pietrantuono G; Morello L; Varettoni M; Vozella F; Malandruccolo L; Scortechini I; Rossi M; Romeo A; Vitale C; Fraticelli V; Galieni P; Innao V; Pocali B; Loseto G; Bulian P; Farina G; et alii...

Venetoclax therapy in chronic lymphocytic leukaemia patients relapsed after allogeneic haematopoietic stem cell transplantation. in British journal of haematology / Br J Haematol. 2025 Mar;206(3):924-929. doi: 10.1111/bjh.19976. Epub 2025 Jan 7.
2025
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Bruno B; Rambaldi A; Laurenti L; Gaidano G; Krampera M; Rivela P; Quaresmini G; Quaglia FM; Moia R; Innocenti I; Frustaci AM; Deodato M; Catania G; Montalbano MC; Boccellato E; Perutelli F; Vitale C; Coscia M;

The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL. in American journal of hematology / Am J Hematol. 2023 Dec;98(12):1856-1868. doi: 10.1002/ajh.27093. Epub 2023 Sep 29.
2023
AOU Alessandria
AOU Città della Salute di Torino
AOU Novara

De Paoli L; De Paolis MR; Delgado J; Dimou M; Donaldson D; Catherwood M; Doubek M; Efstathopoulou M; Eichhorst B; Elashwah S; Enrico A; Espinet B; Farina L; Ferrari A; Stamatopoulos K; Ghia P; Stavroyianni N; Trentin L; Cuneo A; Montserrat E; Vitale C; Coscia M; Rambaldi A; Iyengar S; Varettoni M; Yassin M; Pocali B; Vandenberghe E; van Kampen R; et alii...

Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study. in Blood advances / Blood Adv. 2022 Jul 12;6(13):3875-3878. doi: 10.1182/bloodadvances.2022006964.
2022
AOU Alessandria
AOU Città della Salute di Torino

Trentin L; Angeletti I; Coscia M; Patti C; Sanna A; Murru R; Sapienza G; Cuccaro A; Marasca R; Sportoletti P; Morelli F; Chiarenza A; Vitale C; Moretti M; Tomasso A; Visentin A; Catania G; Piciocchi A; Autore F; Fresa A; Pietrasanta D; Innocenti I; Laurenti L;

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study. in Leukemia / Leukemia. 2021 Dec;35(12):3444-3454. doi: 10.1038/s41375-021-01450-8. Epub 2021 Nov 1.
2021
AOU Alessandria
AOU Città della Salute di Torino
AOU Novara

Ghia P; Stamatopoulos K; Foà R; Cuneo A; Montserrat E; Rambaldi A; Coscia M; Yassin M; San Segundo LY; Wasik-Szczepanek E; Wróbel T; Visentin A; Vitale C; van Gelder M; van Kampen R; Varettoni M; Van Der Spek E; Trentin L; Tonino SH; Te Raa D; Tadmor T; Špa?ek M; Sportoletti P; Stavroyianni N; Stanca O; Shrestha A; Šimkovi? M; Saghumyan G; Qvist K; et alii...